St James' Institute of Oncology
Leeds, United Kingdom
Cancer treatment center in Leeds, England
Bexley Wing, Beckett St, Harehills, Leeds LS9 7LP
About St James' Institute of Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
CCTU- Cancer Theme
1
Celgene
1
Heidelberg Pharma AG
1
Pfizer
1
Scancell Ltd
1
Taiho Oncology, Inc.
1
United Therapeutics
1
University College, London
1
Clinical Trials at St James' Institute of Oncology
During the past decade, St James' Institute of Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
2007-07-01
2014-09-01
Completed
223
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
2010-09-02
2018-04-05
Completed
111
Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours
2012-03-01
2014-04-01
Terminated
41
Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
2012-06-17
2016-05-23
Completed
800
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
2015-01-13
2018-11-08
Completed
931
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "St James' Institute of Oncology" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "CCTU- Cancer Theme" with 1 trials
sponsored, "Celgene" with 1 trials sponsored, "Heidelberg Pharma AG" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "St James' Institute of Oncology"
#1 collaborator was "Cancer Research UK" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator and "NCRI Radiotherapy Trials QA (RTTQA) Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at St James' Institute of Oncology
According to Clinical.Site data, the most researched conditions in "St James' Institute of Oncology" are
"Colorectal Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Advanced Gastric Cancer" (1 trials), "Advanced Solid Tumours" (1 trials) and "Advanced/Metastatic Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "St James' Institute of Oncology" in a lesser frequency.
Clinical Trials Intervention Types at St James' Institute of Oncology
Most popular intervention types in "St James' Institute of Oncology" are "Drug" (8 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine" (2 trials), "Oxaliplatin" (2 trials), "5-Fluorouracil (5-FU)" (1 trials), "Abraxane (nab-paclitaxel)" (1 trials) and "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St James' Institute of Oncology
The vast majority of trials in "St James' Institute of Oncology" are
10 trials for "All" genders.
Clinical Trials Status at St James' Institute of Oncology
Currently, there are NaN active trials in "St James' Institute of Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in St James' Institute of Oncology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in St James' Institute of Oncology, 2 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".